Carbapenems are considered as last-resort antibiotics for the treatment of infections caused
by multidrug-resistant Gram-negative bacteria. With the increasing use of carbapenems in …

After the first aminoglycoside antibiotic streptomycin being applied in clinical practice in the
mid-1940s, aminoglycoside antibiotics (AGAs) are widely used to treat clinical bacterial …

These updated guidelines from the Infectious Diseases Community of Practice of the
American Society of Transplantation review the diagnosis, prevention, and management of …

Plazomicin is a novel semisynthetic parenteral aminoglycoside that inhibits bacterial protein
synthesis. It was approved by the United States Food and Drug Administration for use in …

Abstract In 2016 the American Burn Association held a State of the Science conference to
help identify burn research priorities for the next decade. The current paper summarizes the …

Bacteria within the genus Acinetobacter (principally A. baumannii-calcoaceticus complex
[ABC]) are gram-negative coccobacilli that may cause nosocomial infections in critically ill or …

A gradual rise in drug-resistant trends among Gram-negative organisms, especially
carbapenem-resistant (CR) Enterobacteriaceae (CRE), CR-Pseudomonas aeruginosa, and …

Cefiderocol is a new siderophore cephalosporin that is effective against multidrug-resistant
Gram-negative bacteria, including carbapenem-resistant strains. The aim of this study was to …

Abstract Infections by Carbapenem-Resistant Enterobacteriaceae (CRE), in particular,
carbapenem-resistant Klebsiella pneumoniae (CRKp), are a significant public health …

Introduction: The spread of extended-spectrum β–lactamase (ESBL)-producing
Enterobacteriaceae has become a major public health threat worldwide. Area covered: A …